Study results from Amgen, Inc. broaden understanding of bioengineering

Investigators publish new data in the report 'Mass spectrometric-based stable isotopic 2-aminobenzoic acid glycan mapping for rapid glycan screening of biotherapeutics.' According to recent research from the United States, "Fast, sensitive, robust methods for 'high-level' glycan screening are necessary during various stages of a biotherapeutic product's lifecycle, including clone selection, process changes, and quality control for lot release testing. Traditional glycan screening involves chromatographic or electrophoretic separation-based methods, and, although reproducible, these methods can be time-consuming."

"Even ultrahigh-performance chromatographic and...

Want to see the full article?

• Purchase this article for only $3.00